LAURUSLABSPharmaceuticals
Laurus Labs Ltd — Profit & Loss Statement
₹992.70
-1.44%
Laurus Labs Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | 3.56 Cr | 2.26 Cr | 2.30 Cr | 2.31 Cr | — |
| Diluted Average Shares | 53.96 Cr | 53.97 Cr | 53.96 Cr | 53.92 Cr | — |
| Basic Average Shares | 53.92 Cr | 53.87 Cr | 53.77 Cr | 53.68 Cr | — |
| Diluted EPS | 6.64 | 2.97 | 14.64 | 15.35 | — |
| Basic EPS | 6.65 | 2.98 | 14.69 | 15.42 | — |
| Diluted NI Availto Com Stockholders | 358.32 Cr | 160.55 Cr | 790.11 Cr | 827.52 Cr | — |
| Net Income Common Stockholders | 358.32 Cr | 160.55 Cr | 790.11 Cr | 827.52 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 358.32 Cr | 160.55 Cr | 790.11 Cr | 827.52 Cr | — |
| Minority Interests | -0.02 Cr | -1.72 Cr | -3.32 Cr | -4.71 Cr | — |
| Net Income Including Noncontrolling Interests | 358.34 Cr | 162.27 Cr | 793.43 Cr | 832.23 Cr | — |
| Net Income Continuous Operations | 358.34 Cr | 162.27 Cr | 793.43 Cr | 832.23 Cr | — |
| Tax Provision | 129.88 Cr | 68.15 Cr | 312.30 Cr | 251.42 Cr | — |
| Pretax Income | 484.29 Cr | 236.36 Cr | 1.11K Cr | 1.08K Cr | — |
| Other Non Operating Income Expenses | 0.02 Cr | 0.01 Cr | 1.04 Cr | 0.87 Cr | — |
| Special Income Charges | 57.05 Cr | 15.12 Cr | 0.19 Cr | 0.56 Cr | — |
| Other Special Charges | -57.05 Cr | -15.12 Cr | 0.21 Cr | 1.21 Cr | — |
| Net Non Operating Interest Income Expense | -197.46 Cr | -174.05 Cr | -138.03 Cr | -90.24 Cr | — |
| Total Other Finance Cost | 6.04 Cr | 7.90 Cr | 19.70 Cr | 16.20 Cr | — |
| Interest Expense Non Operating | 206.59 Cr | 171.76 Cr | 122.89 Cr | 75.76 Cr | — |
| Interest Income Non Operating | 15.17 Cr | 5.61 Cr | 4.56 Cr | 1.72 Cr | — |
| Operating Income | 625.18 Cr | 394.87 Cr | 1.29K Cr | 1.17K Cr | — |
| Operating Expense | 2.34K Cr | 2.11K Cr | 1.88K Cr | 1.47K Cr | — |
| Other Operating Expenses | 929.57 Cr | 875.23 Cr | 793.00 Cr | 566.04 Cr | — |
| Depreciation And Amortization In Income Statement | 430.10 Cr | 384.57 Cr | 324.08 Cr | 251.49 Cr | — |
| Amortization | 5.85 Cr | 4.91 Cr | — | — | — |
| Depreciation Income Statement | 424.25 Cr | 379.66 Cr | 324.08 Cr | 251.49 Cr | — |
| Research And Development | 55.30 Cr | 43.76 Cr | 25.59 Cr | 29.47 Cr | — |
| Selling General And Administration | 251.32 Cr | 201.12 Cr | 179.96 Cr | 163.78 Cr | — |
| Selling And Marketing Expense | 170.95 Cr | 134.49 Cr | 116.14 Cr | 101.98 Cr | — |
| General And Administrative Expense | 80.37 Cr | 66.63 Cr | 63.82 Cr | 61.80 Cr | — |
| Rent And Landing Fees | 3.56 Cr | 2.26 Cr | 2.30 Cr | 2.31 Cr | — |
| Gross Profit | 2.97K Cr | 2.50K Cr | 3.17K Cr | 2.64K Cr | — |
| Cost Of Revenue | 2.54K Cr | 2.50K Cr | 2.84K Cr | 2.25K Cr | — |
| Total Revenue | 5.51K Cr | 5.00K Cr | 6.01K Cr | 4.89K Cr | — |
| Operating Revenue | 5.51K Cr | 5.00K Cr | 6.01K Cr | 4.89K Cr | — |
| Tax Effect Of Unusual Items | 15.30 Cr | 4.36 Cr | 0.05 Cr | 0.13 Cr | — |
| Tax Rate For Calcs | 0.27 | 0.29 | 0.28 | 0.23 | — |
| Normalized EBITDA | 1.06K Cr | 777.58 Cr | 1.56K Cr | 1.41K Cr | — |
| Total Unusual Items | 57.05 Cr | 15.12 Cr | 0.19 Cr | 0.56 Cr | — |
| Total Unusual Items Excluding Goodwill | 57.05 Cr | 15.12 Cr | 0.19 Cr | 0.56 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 358.32 Cr | 160.55 Cr | 790.11 Cr | 827.52 Cr | — |
| Reconciled Depreciation | 430.09 Cr | 384.58 Cr | 324.08 Cr | 251.49 Cr | — |
| Reconciled Cost Of Revenue | 2.54K Cr | 2.50K Cr | 2.84K Cr | 2.25K Cr | — |
| EBITDA | 1.12K Cr | 792.70 Cr | 1.56K Cr | 1.41K Cr | — |
| EBIT | 690.88 Cr | 408.12 Cr | 1.23K Cr | 1.16K Cr | — |
| Net Interest Income | -197.46 Cr | -174.05 Cr | -138.03 Cr | -90.24 Cr | — |
| Interest Expense | 206.59 Cr | 171.76 Cr | 122.89 Cr | 75.76 Cr | — |
| Interest Income | 15.17 Cr | 5.61 Cr | 4.56 Cr | 1.72 Cr | — |
| Normalized Income | 316.57 Cr | 149.79 Cr | 789.97 Cr | 827.09 Cr | — |
| Net Income From Continuing And Discontinued Operation | 358.32 Cr | 160.55 Cr | 790.11 Cr | 827.52 Cr | — |
| Total Expenses | 4.88K Cr | 4.61K Cr | 4.72K Cr | 3.72K Cr | — |
| Write Off | — | 0.00 | -0.40 Cr | -1.77 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Laurus Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.